Results 201 to 210 of about 7,941 (258)
Some of the next articles are maybe not open access.
Immunoprophylaxis of viral hepatitis
Postgraduate Medicine, 1988Because safe, effective treatment for established viral hepatitis is not available, physicians need to be acquainted with recent advances in prophylaxis. Immune globulin (Gamastan, Gammar) is used for both preexposure and postexposure prophylaxis of hepatitis A, and side effects are rare.
openaire +2 more sources
Developmental Period Medicine, 2018
Background Respiratory syncytial virus infection causes respiratory diseases in about 90% of the children under 2 years of age. Currently the only way to prevent infection is through immunoprophylaxis based on palivizumab. Aim The aim of the study was to
Róża Borecka, R. Lauterbach
semanticscholar +1 more source
Background Respiratory syncytial virus infection causes respiratory diseases in about 90% of the children under 2 years of age. Currently the only way to prevent infection is through immunoprophylaxis based on palivizumab. Aim The aim of the study was to
Róża Borecka, R. Lauterbach
semanticscholar +1 more source
Immunoprophylaxis of Otitis Media
1991Prospects for an effective otitis media vaccine are bolstered by a number of encouraging observations. Results of pneumococcal polysaccharide vaccine trials beginning in 1975, the enormously enhanced immunogenicity of protein-Hib polysaccharide coupled vaccines in infants, and the apparent effectiveness of a protein-PCP coupled vaccine in experimental ...
openaire +2 more sources
Immunoprophylaxis for travellers.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2020When planning a journey to a destinations where infectious diseases are endemic one needs to undertake appropriate prophylactic measures in order to reduce the risk of developing a travel-related health problem. It is important that a traveller undergoes a medical examination before travel, makes sure that his travel first-aid kit includes all the ...
Krzysztof, Korzeniewski +1 more
openaire +1 more source
Immunoprophylaxis With RespiGam
PEDIATRICS, 2004To the Editor. — Guidelines for immunoprophylaxis with RespiGam and palivizumab for prevention of respiratory syncytial virus (RSV) infection in high-risk infants and children have been issued and updated by the American Academy of Pediatrics (AAP) Committee on Infectious Diseases and Committee on Fetus and Newborn.1,2 Prais et al3 reported results of
H. Cody Meissner +3 more
openaire +1 more source
Immunoprophylaxis and immunotherapy of EL4 lymphoma
European Journal of Cancer (1965), 1977Abstract Injections of appropriate numbers of irradiated, but not iodoacetate treated, EL4 lymphoma cells into C57BL/6J mice were effective in immunoprophylaxis against 106 EL4 cells and in immunotherapy against 102 EL4 cells per mouse. The addition of BCG injections made immunotherapy with irradiated EL4 cells effective against a load of 104 EL4 ...
Ghose, T +4 more
openaire +2 more sources
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
Proceedings of the National Academy of Sciences of the United States of America, 2023Takuya Tada, Nathaniel R Landau
exaly
FAILURES OF Rh IMMUNOPROPHYLAXIS
The Lancet, 1971J, Jorgensen, E, Freiesleben
openaire +4 more sources
Immunoprophylaxis for travellers
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1970openaire +2 more sources